Capio's CEO Thomas Berglund to Leave his Position When Successor is in Place
GOTHENBURG, Sweden, Feb. 7, 2018 /PRNewswire/ -- Thomas Berglund has informed the Capio Board of Directors that he wishes to leave his position as President and CEO of Capio. Thomas has been with Capio for more than 10 years, of which the first three years as working Chairman of the Board and since 2011 in his current position.
The Board of Directors has today agreed with Thomas Berglund, notwithstanding his current employment agreement that he will continue his work with unabated power until a successor is in place. The Board of Directors has also decided to start a recruitment process supported by an external executive search company to find a new President and CEO.
"It is exiting and a privilege to develop Swedish and international healthcare together with all knowledgeable and dedicated people in Capio. I know that we make a difference, both within and outside of Sweden. After more than 30 years as a business executive, of which 10 years with Capio, it is time to hand over responsibility. Capio is now developing into a new phase where the digital breakthrough will provide healthcare professionals with new and fantastic tools and for the patient, digitalization will mean improved accessibility and influence over its own care" says Thomas Berglund.
"Under the management of Thomas Berglund, Capio has been leading the development of Modern Medicine and Rapid Recovery with a clear patient focus. The Board of Directors and the management will now leverage the strong platform built to increase focus on growth through further specialization and digitalization of the business. This will also be reflected in the recruitment process ahead", says Michael Wolf, Chairman of the Board in Capio AB.
Chairman of the Board
This is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.01 (CET) on February 7, 2018.
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2017, Capio's 13,314 employees (average full-time equivalents) provided healthcare services during 5.1 million patient visits across the Group's facilities, generating net sales of MSEK 15,327. Capio operates across three geographic segments: Nordic (57% of Group net sales 2017), France (35% of Group net sales 2017) and Germany (8% of Group net sales 2017). For more information about Capio, please see www.capio.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Upcoming Life Sciences Events
- February 2019
- Zurich: Swiss Nordic Bio 2019
- New York: BIO CEO & Investor Conference
- March 2019
- Tokyo: BIO Asia International Conference